EUVIMEDEUVIMED entdecken
Crossref

Pharmacokinetics of collagen dipeptides (Gly–Pro and Pro–Hyp) and tripeptides (Gly–Pro–Hyp) in rats

Jihyun Won, Juhyung Kang iD, Keumhan Noh, Hee-Chul Chung, Wonku Kang

Journal of Food Science · 2024-01 · 89 (1) · 701-709

DOI: 10.1111/1750-3841.16871 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Food Science, online erschienen am 05.12.2023. Verfasst von Jihyun Won und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Chung-Ang University, Seoul, South Korea. Hauptthemen laut MEDLINE: Dipeptides, Collagen, Oligopeptides. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: National Research Foundation of Korea, Ministry of Food and Drug Safety of South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although systemic exposure to peptides, such as Gly–Pro–Hyp, Pro–Hyp, and Gly–Pro, has been reported following administration of collagen hydrolysates from fish scale and porcine skin in vivo, the individual peptide pharmacokinetics remain unknown. We administered the three peptides individually to rats via the intravenous (5 mg/kg) and intragastric (100 mg/kg) routes and then monitored systemic exposure and urinary excretion. The peptides in biological samples were analyzed via liquid chromatography/tandem mass spectrometry. Gly–Pro–Hyp tended to exhibit higher first‐pass metabolism than Pro–Hyp; the absolute oral bioavailabilities of Gly–Pro–Hyp and Pro–Hyp were 4.4% and 19.3%, respectively. Gly–Pro levels were very low in the systemic circulation. Pro–Hyp biotransformed from Gly–Pro–Hyp behaved similarly to Pro–Hyp alone when administered orally. Flip‐flop kinetics (elimination rate ≫ absorption rate) were evident, probably reflecting transporter‐mediated slow absorption. A double‐peak phenomenon was observed for Gly–Pro–Hyp and Pro–Hyp when administered orally, and 5.9% ± 2.6% and 1.9% ± 0.3% of each dose were excreted in urine after intravenous administration, respectively. Urinary recovery of Gly–Pro was limited to 0.4% ± 0.5% of the intravenous dose. This work represents the first individual pharmacokinetics of Gly–Pro–Hyp, Pro–Hyp, and Gly–Pro in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DipeptidesCollagenOligopeptidesRatsAnimalsPeptides

Stichwörter der Autor:innen

Gly-ProGly-Pro-HypPro-Hyppharmacokineticsrats

Substanzen

glycylprolineglycyl-prolyl-hydroxyprolineDipeptidesCollagenPeptidesOligopeptides

Autor:innen und Institutionen

  • College of Pharmacy, Chung-Ang University, Seoul, South Korea.
  • Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.
  • Department of Health food R&D, Newtree Co., Ltd., Seoul, South Korea.

ORCID-Profile: Juhyung Kang

Förderung

  • National Research Foundation of Korea
  • Ministry of Food and Drug Safety of South Korea

Zitieren

APA

Won, J., Kang, J., Noh, K., Chung, H. C., & Kang, W. (2024). Pharmacokinetics of collagen dipeptides (Gly–Pro and Pro–Hyp) and tripeptides (Gly–Pro–Hyp) in rats. Journal of Food Science, 89(1), 701-709. https://doi.org/10.1111/1750-3841.16871

Vancouver

Won J, Kang J, Noh K, Chung HC, Kang W. Pharmacokinetics of collagen dipeptides (Gly–Pro and Pro–Hyp) and tripeptides (Gly–Pro–Hyp) in rats. Journal of Food Science. 2024;89(1):701-709. doi:10.1111/1750-3841.16871

BibTeX
@article{Won2024,
  author = {Won, Jihyun and Kang, Juhyung and Noh, Keumhan and Chung, Hee-Chul and Kang, Wonku},
  title = {Pharmacokinetics of collagen dipeptides (Gly–Pro and Pro–Hyp) and tripeptides (Gly–Pro–Hyp) in rats},
  journal = {Journal of Food Science},
  year = {2024},
  volume = {89},
  number = {1},
  pages = {701--709},
  doi = {10.1111/1750-3841.16871}
}
Kostenlos starten →